CYSTEINPROTEASE

Patent europeic · EP3256579 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3256579
Numer da la dumonda
EP16704223
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-02-2016
Publitgà
20-12-2017
Concedì
30-08-2023
La protecziun finescha il pli tard
11-02-2036
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C12N 9/24 (2006.01)
Prioritad
GB 201502305 12.02.2015
Dumonda PCT
PCT/EP2016/053054 12.02.2016
Publicaziun PCT
WO2016/128559 18.08.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  3. 10-07-2024

    Midada

    Published in Swissreg on 10.07.2024

  4. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  5. 08-11-2023

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 08.11.2023

  6. 30-08-2023

    Concedì

    Published in Swissreg on 30.08.2023

Partidas

Possessur

Hansa Biopharma AB

Box 785, 220 07 Lund, SE

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

JARNUM, Sofia

220 07 Lund, SE

KJELLMAN, Christian

220 07 Lund, SE

NORDAHL, Emma

220 07 Lund, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.